Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

Trial Profile

Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jul 2013

At a glance

  • Drugs Landiolol (Primary)
  • Indications Supraventricular tachycardia
  • Focus Therapeutic Use
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 02 Jul 2013 Primary endpoint 'Heart-rate' has been met.
    • 26 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top